3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Withdrawn
1
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
9
Rectal Neoplasms
2
Carcinoma, Hepatocellular
2
Urachal cancer
1
Pancreatic Adenocarcinoma
1
Neoplasms
1
Colorectal Neoplasms
1
Borderline Resectable Pancreatic Cancer
1
Interventions
Exercise
19
Drug Therapy
18
pembrolizumab
13
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Paclitaxel
9
Dexamethasone
9
Nivolumab
8
Standard of Care
7
Oxaliplatin
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Control Groups
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
folfirinox
×
Clear all
NCT01676259
2021-07-02
PROTACT
Silenseed Ltd
Phase 2
Unknown
80 enrolled